PerkinElmer Streamlines Flow Cytometry Management For Biopharmaceutical Labs with New OneSource Concierge Service

WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has added PerkinElmer Flow Cytometry Instrument Concierge Services to its OneSource® Laboratory Services portfolio. The comprehensive and flexible offering will provide biopharmaceutical labs with expert, onsite flow cytometry specialists to help manage their instruments and processes more efficiently... Read more

Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research

Three Labs in Japan and Spain to Receive Novel Compact Ascend Evo 1.0 GHz Magnets UTRECHT, The Netherlands–(BUSINESS WIRE)– At the Euromar 2022 Conference, Bruker announced three new customer orders for GHz systems, which will incorporate novel, compact 1.0 GHzNMR magnets for structural biology applications and clinical research in single-story laboratories. The new Ascend Evo... Read more

GE Healthcare Inaugurates its First ‘5G Innovation Lab’ Aimed at Transforming Remote Care

To accelerate access to quality care by employing 5G-enabled healthcare solutions – Artificial Intelligence, Augmented & Virtual Reality and Advanced Visualization, to streamline image transfers, teleradiology Foster collaboration with academia, industry and startups to co-create future-ready solutions Bengaluru, July 7, 2022: GE Healthcare, a leading global medical technology, diagnostics, and digital solutions innovator, today inaugurated... Read more

Neogen Acquires Distributor in Thailand

July 06, 2022 LANSING, Mich., July 6, 2022 — Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired Thai-Neo Biotech Co., Ltd., a longstanding distributor of Neogen’s food safety products located in Bangkok, Thailand. Thai-Neo Biotech was established in 1992 and has served as a distributor of Neogen food safety products, especially mycotoxin assays... Read more

Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment

ETTLINGEN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today has launched PhenoRiskPACS™ RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ blood samples, using a multiplexed combination of biomarkers discovered at the Australian National Phenome Center (ANPC) at Murdoch University, under Director Jeremy Nicholson. The PhenoRiskPACS™ RuO test is promising for research... Read more